November 30, 2025

November 29, 2025

November 28, 2025

November 26, 2025

November 24, 2025

Ozempic Fails to Slow Alzheimer's Progression in Phase 3 Trials

“While semaglutide did not demonstrate efficacy in slowing the progression of Alzheimer’s disease, the extensive body of evidence supporting semaglutide continues to provide benefits for individuals with type 2 diabetes, obesity, and related comorbidities.”

November 22, 2025

November 21, 2025

November 19, 2025

November 18, 2025

November 17, 2025

November 15, 2025

November 14, 2025

November 13, 2025

November 12, 2025

November 11, 2025

November 10, 2025

November 9, 2025

November 8, 2025

November 7, 2025

November 5, 2025

November 4, 2025

November 3, 2025

November 1, 2025